What is Pharmaceutical Tech Transfer?
Moving a drug substance or drug product manufacturing process from one site to another while maintaining consistent quality, regulatory compliance, and supply continuity. The documented version of that move is the tech transfer package — and it is one of the highest-leverage, highest-risk activities in pharma operations.
Short answer. Tech transfer is the documented move of a manufacturing process between sites (Sending Unit to Receiving Unit). The objective is consistent product quality across the move with full regulatory defensibility. WHO Technical Report Series 961 Annex 7 and the ISPE Good Practice Guide: Technology Transfer are the reference documents most sponsors use.
Reference guidance
- WHO TRS 961 Annex 7 — "Guidelines on Transfer of Technology in Pharmaceutical Manufacturing." Defines Sending Unit and Receiving Unit roles, project phases, and documentation requirements.
- ISPE Good Practice Guide: Technology Transfer (current edition) — practical implementation guidance with templates.
- ICH Q5E — Comparability of Biotechnological/Biological Products Subject to Changes in Their Manufacturing Process. Used as the framework for sending-vs-receiving equivalence even for small molecules.
- ICH Q8(R2), Q9(R1), Q10, Q11, Q12 — the pharmaceutical development, risk, PQS, drug substance, and lifecycle management framework the transfer is executed inside.
- ICH Q1A(R2), Q1D, Q1E — stability study design, bracketing / matrixing, evaluation for shelf-life determination.
- 21 CFR 211, EU GMP Part I, Health Canada Division 2 — the GMP regulations both sites operate under.
Phases of a typical tech transfer
- Feasibility and kickoff. Receiving site assessment, gap analysis, Quality Agreement drafting, tech transfer steering committee.
- Process and analytical transfer. Process description handoff, analytical method transfer per USP <1224>, reference standard qualification, comparability protocol execution.
- Equipment qualification and process performance qualification (PPQ). IQ/OQ/PQ of new equipment, at-scale engineering batches, exhibit batches.
- Stability and regulatory. Stability program initiation per ICH Q1, filing per regional change-control pathway (FDA CBE-30 / PAS, EMA Type IA/IB/II, Health Canada Notifiable Change / SANDS).
- Commercial and closure. Release of first commercial batch from the receiving site, lessons-learned, archival of transfer documentation.
Common failure modes
- Analytical method transfer failure. Methods that ran cleanly at the sending site fail acceptance at the receiving site — typically traced to reference standard handling, column brand, or instrument qualification deltas.
- Raw material equivalence. Receiving site sources from a different supplier and the impurity profile shifts.
- Equipment delta. Nominally-equivalent equipment behaves differently (mixing time, granulation endpoint, tablet hardness profile).
- Comparability acceptance criteria too loose or too tight. TOST or equivalence bounds set without proper statistical power.
- Regulatory misclassification. A change classified as Notifiable when it should have been Type IB or a PAS.
Related glossary entries
Frequently asked questions
What is pharmaceutical tech transfer?
The documented process of moving a drug substance or drug product manufacturing process between sites while maintaining consistent quality. Governed primarily by WHO TRS 961 Annex 7 and the ISPE Good Practice Guide: Technology Transfer.
What triggers a tech transfer?
Site change (divestment, acquisition, consolidation), contract manufacturing outsourcing or insourcing, scale-up, geographic expansion, or second-source capacity for supply resilience.
What does a transfer package include?
QTPP, process description, CPP/CQA linkage, equipment and facility delta, comparability protocol, analytical method transfer plan, specifications, stability protocol, risk register, regulatory filing strategy, and Gantt timeline.
How long does a typical tech transfer take?
9-18 months for a solid oral generic. 18-36 months for a biologic or sterile injectable. Critical path usually runs through equipment qualification, analytical method transfer, comparability batches, and stability program build-out.